ArticleInternational journal of molecular sciences2025

MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma.

Ilaria Leoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.